Molecular modeling of enantiomeric resolution of methylphenidate on cellulose tris benzoate chiral stationary phase

Journal of Liquid Chromatography and Related Technologies

Volumn 25, Issue 18, 2002, Pages 2739-2748

  Aboul Enein, Hassan Y ^a   Ali, Imran ^a   Laguerre, Michel ^b   Felix, Guy ^c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b INSTITUT EUROPÉEN DE CHIMIE ET BIOLOGIE   (France)

^c Ecole Nationale Superieure de Chimie et de Physique de Bordeaux   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID CHROMATOGRAPHY; PHENOLS; ULTRAVIOLET DETECTORS;

ENANTIOMERS;

ORGANIC ACIDS;

ALCOHOL; BENZOIC ACID; HEXANE; METHANOL; METHYLPHENIDATE; PHENOL; TRIFLUOROACETIC ACID;

ARTICLE; CHIRALITY; DRUG DETERMINATION; DRUG STRUCTURE; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR MODEL; SIMULATION; STOCHASTIC MODEL; ULTRAVIOLET RADIATION;

EID: 0036405383     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120014946     Document Type: Article

References (21)

1. Yashima, E.; Okamoto, Y. Chiral recognition mechanism of polysaccharides chiral stationary phases. In The Impact of Stereochemistry on Drugs Development and Use; Aboul-Enein, H.Y., Wainer, I.W., Eds.; John Wiley & Sons: New York, USA, 1997; Vol. 142, 345.
2. Beesley, T.E.; Scott, R.P.W. Chiral Chromatography; John Wiley & Sons: New York, USA, 1998; 221.
3. Barkley, R.J. Child Psychol. Psychiatry Allied Discip. 1977, 18, 137.
4. Giarman, N.J. In Drill's Pharmacology in Medicine, 3rd Ed.; McGraw-Hill: New York, USA, 1965; 368.
5. Spencer, TS.; Wilens, T.; Biederman, J.; Faraone, S.V.; Ablon, S.; Lapey, K.A. Arch. Gen. Psychiatry 1995, 52, 434.
6. Klein, R.G. Arch. Gen. Psychiatry 1995, 52, 429.
7. Bruera, D.; Renneis, C.; Paterson, A.H.G.; MacDonald, R.N. Am. J. Nurs. 1988, 11, 1555.
8. Greenhill, L.L.; Osman, B.B. Ritalin: Theory and Patient Management; Liebert: New York, USA, 1991.
9. Levin, F.R.; Evans, M.S.; McDowell, D.M.; Kleber, H.D. J. Clin. Psychiatry 1998, 59, 300.
10. Grabowski, J.; Roache, J.D.; Schmitz, J.M.; Rhoades, H.; Creson, D.; Korszun, A. J. Clin. Psychopharmacol. 1997, 17, 485.
11. Khantzian, E.J.; Gawin, F.H.; Riordan, C.; Kleber, H.D. J. Subs. Abuse Treat. 1984, 1, 107.
12. Maxwell, R.A.; Chaplin, E.; Eckardt, S.B.; Soares, J.R.; Hite, G.J. J. Pharmacol. Exp. Ther. 1970, 173, 158.
13. Srinivas, N.R.; Quinn, D.; Hubbard, J.W.; Midha, K.K. J. Pharmacol. Exp. Ther. 1987, 241, 300.
14. Aboul-Enein, H.Y.; Ali, I. Chirality 2002, 14, 47.
15. Mohamadi, F.; Richards, N.G.J.; Guida, W.C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrikson, T.; Still, W.C. J. Comp. Chem. 1990, 11, 441.
16. Still, W.C.; Tempczyk, A.; Hawley, R.C.; Hendrikson, T. J. Am. Chem. Soc. 1990, 112, 6127.
17. Van Gunsteren, W.F.; Berendsen, H.J.C. Molec. Simul. 1988, 1, 173.
18. Wainer, I.W.; Alembic, M.C. J. Chromatogr. 1986, 358, 85.
19. Wainer, I.W.; Stiffin, R.M.; Shibata, T. J. Chromatogr. 1987, 411, 139.
20. Yamamoto, C.; Yashima, E.; Okamoto, Y. Bull. Chem. Soc. Jpn. 1999, 72, 1815.
21. Aboul-Enein, H.Y. Biomed. Chromatogr. 1998, 12, 116.